Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

16 Nov 2023 Evaluate

Aurobindo Pharma has informed that the officials of the Company will be participating in the investor / analyst meeting arranged by JP Morgan scheduled on 21st November 2023 at 05:30 pm to 06:30 pm at Hyderabad. The type of the meeting is In-person (investor group). No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1346.45
Cipla 1368.95
Lupin 1990.95
Zydus Lifesciences 1187.25
View more..